Last reviewed · How we verify
NCT04503655: FAST-TAVI II
Multicenter Study Evaluating the Efficacy of an Intervention Aimed At Reducing the Length of Stay After Transfemoral Transcatheter Aortic Valve Implantation
NA trial testing Training in Aortic Valve Stenosis in 1,842 participants. Completed in 9 February 2022.
9 February 2022
Quick facts
| Lead sponsor | University Hospital, Rouen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 1,842 |
| Start date | 16 December 2020 |
| Primary completion | 9 February 2022 |
| Estimated completion | 9 February 2022 |
| Sites | 20 locations across France |
Drugs / interventions tested
- Training
Conditions studied
- Aortic Valve Stenosis — all drugs for Aortic Valve Stenosis →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
University Hospital, Rouen
Who can join
18 and older, any sex, with Aortic Valve Stenosis or Cardiovascular Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Since the first implantation of a percutaneous aortic bioprosthesis (TAVI) in 2002 (Cribier et al. Circulation 2002), TAVI occupies an increasing place in the management of aortic stenosis (AR) . Initially reserved for inoperable patients at high surgical risk, TAVI is also recommended in patients at intermediate risk, especially when a femoral approach (TF) is possible (Baumgartner et al. Eur Heart J. 2017). Currently, there is no recommendation regarding length of stay after TAVI and practices are extremely heterogeneous. Despite the growing experience of centers, better patient selection and a reduction in complications, the length of stay after TAVI remains very high in France. Faced with the great disparity observed between the centers, efforts are necessary to educate the centers in order to further reduce the length of stay after TF-TAVI. The aim of the study is to evaluate the effectiveness of an intervention based on training teams to reduce the length of stay after TF-TAVI.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
Durand E, Beziau-Gasnier D, Michel M, Iung B, et al · · 2024 · cited 23× · PMID 38437633 · DOI 10.1093/eurheartj/ehae081
Verify or expand the search:
- PubMed search for NCT04503655
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Training
Trials testing the same drug.
- NCT07379073 — Evaluation of a Clinical Support Website for the Management of Common Mental Health Conditions in Primary Care on Compli · NA · not yet recruiting
- NCT06961942 — Enhancing Endoscopic Scoring Consistency and Accuracy in IBD: a Video-based Training Approach · NA · not yet recruiting
- NCT07202182 — Creative Drama-Based Stress Management Program on Stress, Coping, and Emotional Intelligence · NA · completed
- NCT07533838 — The Effect of Simulation-Based ECG Training on ECG Reading Skills of Nursing Students · NA · completed
- NCT06849440 — Effectiveness of Childbirth Preparation Education · NA · completed
Other recruiting trials for Aortic Valve Stenosis
Currently open trials in the same condition.
- NCT07455292 — Phenotyping Left Ventricle Failure With Hemodynamic Biomarkers From 4D Flow Magnetic Resonance Imaging · NA · recruiting
- NCT07008911 — CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation · NA · recruiting
- NCT07145463 — Prospective, Multicenter, Randomized Controlled Clinical Study Evaluating the VitaFlow Liberty® Flex Transcatheter Aorti · NA · recruiting
- NCT07520656 — Impact of Transcatheter Aortic Valve Implantation and Mitral Valve Repair on Sleep-Disordered Breathing · recruiting
- NCT07267117 — Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease · recruiting
Other University Hospital, Rouen trials
Trials by the same sponsor.
- NCT07441564 — Evaluation of the Efficacy of Ischemic Preconditioning to Protect Against Acute Kidney Injury After Open Surgery for Jux · NA · not yet recruiting
- NCT07535944 — Prospective Exploration of Vascular Complications Associated With the Use of Immune Checkpoint Inhibitors · not yet recruiting
- NCT07464184 — Evolution of Hypoxic Burden and Sympathetic/Parasympathetic Balance in Patients With Pulmonary Hypertension · NA · not yet recruiting
- NCT07359885 — Prediction of Postoperative Pulmonary Complications in Thoracic Surgery · not yet recruiting
- NCT07247500 — Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04503655 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Rouen
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04503655.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing